Author:
Robertson J. F. R.,Ellis I. O.,Nicholson R. I.,Robins A.,Bell J.,Blamey R. W.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Willis JK, London DR, Ward HWC, Butt WR, Lynch SS, Budd BJ: Recurrent breast cancer treated with the anti-oestrogen tamoxifen; correlation between hormonal changes and clinical course. Br Med J 1: 425–428, 1977
2. Groom GU, Griffiths K: Effects of the antioestrogen tamoxifen on the plasma levels of luteinising hormone, follicle stimulating hormone, prolactin, oestradiol and progesterone in normal premenopausal women. J Endocrinol 70: 421–428, 1976
3. Raudin PM, Fritz NF, Twomey DC, Jordan VC: Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res 48: 1026–1029, 1988
4. Farr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen: Pharmac Ther 25: 127–205, 1984
5. Blamey RW, Bishop HM, Blake JRS, Doyle PJ, Elston CW, Haybittle JC, Nicholson RI, Griffiths K: Relationship between primary breast tumour receptor status and patient survival. Cancer 46: 2765–2769, 1980
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献